Reference : Peripheral vascular surgery: Update on the perioperative non-surgical management for ...
Scientific journals : Letter to the editor
Human health sciences : Surgery
http://hdl.handle.net/2268/853
Peripheral vascular surgery: Update on the perioperative non-surgical management for high cardiac risk patients
English
Stammet, P. [> > > >]
Senard, Marc mailto [Centre Hospitalier Universitaire de Liège - CHU > > Anesthésie et réanimation >]
Roediger, Laurence mailto [Centre Hospitalier Universitaire de Liège - CHU > > Anesthésie et réanimation >]
Hubert, Marie-Bernard mailto [Centre Hospitalier Universitaire de Liège - CHU > > Anesthésie et réanimation >]
Larbuisson, Robert mailto [Centre Hospitalier Universitaire de Liège - CHU > > Anesthésie et réanimation >]
Lamy, Maurice mailto [Université de Liège - ULg > Département des sciences cliniques > Département des sciences cliniques >]
Jun-2003
Acta Chirurgica Belgica
Acta Medical Belgica
103
3
248-254
Yes (verified by ORBi)
National
0001-5458
Brussels
[en] perioperative care ; peripheral vascular surgery ; preoperative evaluation ; beta-blockers ; aspirin ; general anaesthesia ; neuraxial loco-regional anaesthesia
[en] This review of the recent literature regarding perioperative management in peripheral vascular surgery emphasizes some of the important features for the 2003 state-of-the-art on non surgical perioperative care for these high cardiac risk patients. The most adapted preoperative cardiac evaluation for each patient is guided by its individual risk factors and clinical history. Perioperative medication should nowadays consist of pre- and postoperative beta-blockers and acetyl salicylic acid, both reducing cardiac morbidity and mortality. Neuraxial locoregional anaesthesia techniques are reasonable alternatives to general anaesthesia because of their potential advantages, by reducing postoperative inflammatory response and reducing procoagulating activity, and increasing peripheral vascular graft patency, but the individual benefit/risk balance has always to be evaluated for patients submitted to aggressive antithrombotic therapy. During the postoperative course, early detection and treatment of postoperative myocardial ischemia or infarction by ST wave changes and/or cardiac enzyme control has to be considered.
http://hdl.handle.net/2268/853

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
362.pdfPublisher postprint698.66 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.